- Home
- MDT
MDT
Medtronic plc.
as 07-26-2024 4:00pm EST
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
| Founded: | 1949 | Country: | Ireland |
| Employees: | N/A | City: | DUBLIN |
| Market Cap: | 109.3B | IPO Year: | N/A |
| Target Price: | $90.82 | AVG Volume (30 days): | 6.3M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.76 | EPS Growth: | -2.13 |
| 52 Week Low/High: | $68.84 - $89.26 | Next Earning Date: | 08-20-2024 |
| Revenue: | $32,364,000,000 | Revenue Growth: | 3.64% |
| Revenue Growth (this year): | 4.26% | Revenue Growth (next year): | 4.76% |
Stock Insider Trading Activity of Medtronic plc. (MDT)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Martha Geoffrey | MDT | Chairman and CEO | Jun 7 '24 | Sell | $83.82 | 1,594 | $133,609.08 | 143,348 | SEC Form 4 |
| Martha Geoffrey | MDT | Chairman and CEO | Jun 7 '24 | Sell | $83.76 | 17,519 | $1,467,391.44 | 144,942 | SEC Form 4 |
| Marinaro Michael | MDT | EVP & President, Surgical OU | Apr 8 '24 | Sell | $83.14 | 854 | $71,001.56 | 27,925 | SEC Form 4 |
| Salmon Sean | MDT | EVP & President Cardiovascular | Feb 21 '24 | Sell | $85.06 | 1,594 | $135,585.64 | 77,390 | SEC Form 4 |
| Salmon Sean | MDT | EVP & President Cardiovascular | Feb 21 '24 | Sell | $85.15 | 13,066 | $1,112,569.90 | 64,324 | SEC Form 4 |
| Salmon Sean | MDT | EVP & President Cardiovascular | Feb 21 '24 | Sell | $85.12 | 16,035 | $1,364,899.20 | 48,289 | SEC Form 4 |
| Wall Brett A. | MDT | EVP & Pres Neuroscience | Dec 19 '23 | Sell | $82.17 | 4,997 | $410,603.49 | 28,910 | SEC Form 4 |
Latest Medtronic plc. News
MDT Breaking Stock News: Dive into MDT Ticker-Specific Updates for Smart Investing
The Wall Street Journal
a day ago
S&P 500’s Biggest Loser Has a Heart Valve Problem
Simply Wall St.
2 days ago
Is Medtronic plc's (NYSE:MDT) Stock On A Downtrend As A Result Of Its Poor Financials?
Zacks
3 days ago
Medtronic (MDT) is a Top-Ranked Value Stock: Should You Buy?
Zacks
4 days ago
Medtronic (MDT) Stock Sinks As Market Gains: Here's Why
MedTech Dive
5 days ago
‘Our next frontier is prediction’: Medtronic on AI and heart disease
Morningstar Research
6 days ago
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
Morningstar Research
7 days ago
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
Medical Device Network
7 days ago
Medtronic recalls endotracheal tube products
Compare MDT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MDT Medtronic plc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.